Home/Filings/4/0000899243-21-016935
4//SEC Filing

Falconer Ester 4

Accession 0000899243-21-016935

CIK 0001703057other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 8:00 PM ET

Size

7.1 KB

Accession

0000899243-21-016935

Insider Transaction Report

Form 4
Period: 2021-03-19
Falconer Ester
Chief Technology Officer
Transactions
  • Exercise/Conversion

    Share Option (right to buy)

    2021-03-191,000,0000 total
    Exercise: $0.03Exp: 2025-08-04Common Shares (1,000,000 underlying)
  • Exercise/Conversion

    Common Shares

    2021-03-19$0.03/sh+1,000,000$34,3001,000,000 total
Footnotes (2)
  • [F1]The exercise price reported above was converted from the Canadian exercise price of CAD $0.0450 using an exchange rate on August 4, 2015 of CAD $1.313 = US $1.00.
  • [F2]As of the date of the transaction, the option was fully vested and exercisable.

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001844479

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 8:00 PM ET
Size
7.1 KB